Researchers Find Tumor-Based Methylation Patterns as Cancer Biomarkers
Researchers identified cancer biomarkers based on a type of genetic modification that predicts the type of tumor immune environment and patient outcomes.
Read MorePosted by Andy Lundin | May 20, 2022 | Cancer |
Researchers identified cancer biomarkers based on a type of genetic modification that predicts the type of tumor immune environment and patient outcomes.
Read MorePosted by Andy Lundin | May 18, 2022 | Cancer, Company News |
Delfi Diagnostics has entered into a broad research agreement with Memorial Sloan Kettering Cancer Center’s Biomarker Development Program.
Read MorePosted by Andy Lundin | May 10, 2022 | Cancer, Company News |
Datar announced a contract with Artemis DNA, which provides Next Generation Sequencing genetic testing and diagnostic laboratory services.
Read MorePosted by Andy Lundin | Apr 8, 2022 | Cancer |
Research has provided more clues on the origins and progression of certain blood cancers, suggesting new ways to diagnose and treat leukemias.
Read MorePosted by Andy Lundin | Apr 8, 2022 | Lung Cancer |
Researchers found a process to study the actions of circulating tumor cells responsible for cancer recurrence of non-small cell lung cancer.
Read More